Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Kanglaite Injection/Capsules for Treatment of Cancer Cachexia: A Prospective, Multicenter Real World Study of a Large Cohort of Chinese Patients

NCT03631459 is registered in ClinicalTrials.gov with Zhejiang Kanglaite Pharmaceutical Co.Ltd as lead sponsor.

NCT NCT03631459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Kanglaite Injection/Capsules for Treatment of Cancer Cachexia: A Prospective, Multicenter Real World Study of a Large Cohort of Chinese Patients
Lead sponsor
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Phase
Observational
Overall status
Unknown status
Start date
August 20, 2018
Completion date
July 20, 2020
Enrollment
100,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cachexia